Supply Chain

Here are the five latest drugs or medical devices approved by the Food and Drug Administration.

Healthcare leaders are expanding their strategic focus to include the supply chain as a key component to achieve optimized cost savings amid a changing healthcare landscape.

The Food and Drug Administration recently granted Salutaris Medical Devices market clearance for its SMD-Sr90-DA Radionuclide Brachytherapy Source device.

Champlain Valley Physicians Hospital, part of the University of Vermont Health Network, is asking for blood donations amid a serious shortage, according to NBC 5.

The Food and Drug Administration will prolong its review of Roche's multiple sclerosis drug Ocrevus by another three months, reports Reuters.

A bipartisan Senate group on Wednesday shared the findings of a year-long report conducted on the unjustified price hikes of older medications with little to no competition, reports The New York Times.

The Food and Drug Administration on Tuesday approved expanded use of Dexcom's G5 Mobile Continuous Glucose Monitoring System.

Before the Affordable Care Act (ACA) became law, health plans relied on an employer-centric model that was focused entirely on groups rather than members.

Blacksburg, Va.-based eBroselow today launched a new clinical tool to help medical transport teams and emergency department staff safely administer drugs during acute emergency situations.

Retailers like Target are increasingly transforming into small distribution centers, shipping items to customers' homes and serving as a pick up location for online orders, reports the Chicago Tribune.